(S (PP (IN As) (NP (NP (DT an) (JJ analytic) (NN pipeline)) (PP (IN for) (NP (NML (JJ quantitative) (NN imaging)) (NN feature) (NN extraction) (CC and) (NN analysis))))) (, ,) (NP (NNS radiomics)) (VP (VBZ has) (VP (VBN grown) (PP (ADVP (RB rapidly)) (IN in) (NP (DT the) (NN past))) (NP-TMP (QP (DT a) (JJ few)) (NNS years)))) (. .))
(S (NP (NP (JJ Recent) (NNS studies)) (PP (IN in) (NP (NNS radiomics)))) (VP (VBP aim) (S (VP (TO to) (VP (VB investigate) (NP (NP (DT the) (NN relationship)) (PP (IN between) (NP (NP (NNS tumors) (NML (NN imaging) (NNS features))) (CC and) (NP (JJ clinical) (NNS outcomes))))))))) (. .))
(S (VP (VB Open) (S (NP (NN source) (NNS radiomics)) (VP (VBP feature) (S (NP (NNS banks)) (VP (VB enable) (NP (NP (DT the) (NN extraction) (CC and) (NN analysis)) (PP (IN of) (NP (NP (NNS thousands)) (PP (IN of) (NP (JJ predefined) (NNS features))))))))))) (. .))
(S (PP (IN On) (NP (DT the) (JJ other) (NN hand))) (, ,) (NP (NP (JJ recent) (NNS advances)) (PP (IN in) (NP (JJ deep) (NN learning)))) (VP (VBP have) (VP (VBN shown) (NP (NP (JJ significant) (NN potential)) (PP (IN in) (NP (DT the) (NML (JJ quantitative) (JJ medical) (NN imaging)) (NN field)))) (, ,) (S (VP (VBG raising) (NP (NP (DT the) (NN research) (NN question)) (PP (IN of) (SBAR (IN whether) (S (NP (JJ predefined) (NNS radiomics) (NNS features)) (VP (VBP have) (NP (NP (JJ predictive) (NN information)) (PP (IN in) (NP (NN addition)))) (PP (IN to) (NP (NML (JJ deep) (NN learning)) (NNS features)))))))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (PRP we)) (VP (VP (VBP propose) (NP (DT a) (NN feature) (NN fusion) (NN method))) (CC and) (VP (VB investigate) (SBAR (IN whether) (S (NP (NP (DT a) (VBN combined) (NN feature) (NN bank)) (PP (IN of) (NP (NP (JJ deep) (NN learning)) (CC and) (NP (JJ predefined) (NNS radiomics) (NNS features))))) (VP (MD can) (VP (VB improve) (NP (DT the) (NNS prognostics) (NN performance)))))))) (. .))
(S (NP (NP (NN CT) (NNS images)) (PP (IN from) (NP (JJ resectable) (JJ Pancreatic) (NML (NN Adenocarcinoma) (PRN (-LRB- -LRB-) (NP (NN PDAC)) (-RRB- -RRB-))) (NNS patients)))) (VP (VBD were) (VP (VBN used) (S (VP (TO to) (VP (VB compare) (NP (NP (DT the) (NN prognosis) (NN performance)) (PP (IN of) (NP (NP (JJ common) (NN feature) (NML (NN reduction) (CC and) (NN fusion)) (NNS methods)) (CC and) (NP (NP (DT the) (VBN proposed) (NML (NN risk) (HYPH -) (NN score)) (NML (VBN based) (NN feature) (NN fusion)) (NN method)) (PP (IN for) (NP (JJ overall) (NN survival)))))))))))) (. .))
(S (NP (PRP It)) (VP (VBD was) (VP (VBN shown) (SBAR (IN that) (S (NP (DT the) (VBN proposed) (NN feature) (NN fusion) (NN method)) (ADVP (RB significantly)) (VP (VBZ improves) (NP (DT the) (NN prognosis) (NN performance)) (PP (IN for) (NP (NP (JJ overall) (NN survival)) (PP (IN in) (NP (JJ resectable) (NN PDAC) (NNS cohorts))))) (, ,) (S (VP (VBG elevating) (NP (DT the) (NN area)) (PP (IN under) (NP (NNP ROC) (NN curve))) (PP (PP (IN by) (NP (NP (CD 51) (NN %)) (PP (VBN compared) (PP (IN to) (NP (NP (JJ predefined) (NNS radiomics)) (SBAR (S (VP (VBZ features) (ADVP (RB alone)))))))))) (, ,) (PP (IN by) (NP (NP (CD 16) (NN %)) (PP (VBN compared) (PP (IN to) (NP (NML (JJ deep) (NN learning)) (NNS features)) (ADVP (RB alone)))))) (, ,) (CC and) (PP (IN by) (NP (NP (CD 32) (NN %)) (PP (VBN compared) (PP (IN to) (NP (VBG existing) (NML (NML (NN feature) (NN fusion)) (CC and) (NML (NML (NN reduction) (NNS methods)) (PP (IN for) (NP (NP (DT a) (NN combination)) (PP (IN of) (NP (UCP (NML (JJ deep) (NN learning)) (CC and) (ADJP (JJ predefined))) (NNS radiomics))))))) (NNS features)))))))))))))) (. .))
